An atlas on risk factors for type 2 diabetes: a wide-angled Mendelian randomisation study
Affiliations
- PMID: 32895727
- DOI: 10.1007/s00125-020-05253-x
Abstract
Aims/hypothesis: The aim of this study was to use Mendelian randomisation (MR) to identify the causal risk factors for type 2 diabetes.
Methods: We first conducted a review of meta-analyses and review articles to pinpoint possible risk factors for type 2 diabetes. Around 170 possible risk factors were identified of which 97 risk factors with available genetic instrumental variables were included in MR analyses. To reveal more risk factors that were not included in our MR analyses, we conducted a review of published MR studies of type 2 diabetes. For our MR analyses, we used summary-level data from the DIAbetes Genetics Replication And Meta-analysis consortium (74,124 type 2 diabetes cases and 824,006 controls of European ancestry). Potential causal associations were replicated using the FinnGen consortium (11,006 type 2 diabetes cases and 82,655 controls of European ancestry). The inverse-variance weighted method was used as the main analysis. Multivariable MR analysis was used to assess whether the observed associations with type 2 diabetes were mediated by BMI. We used the Benjamini-Hochberg method that controls false discovery rate for multiple testing.
Results: We found evidence of causal associations between 34 exposures (19 risk factors and 15 protective factors) and type 2 diabetes. Insomnia was identified as a novel risk factor (OR 1.17 [95% CI 1.11, 1.23]). The other 18 risk factors were depression, systolic BP, smoking initiation, lifetime smoking, coffee (caffeine) consumption, plasma isoleucine, valine and leucine, liver alanine aminotransferase, childhood and adulthood BMI, body fat percentage, visceral fat mass, resting heart rate, and four plasma fatty acids. The 15 exposures associated with a decreased risk of type 2 diabetes were plasma alanine, HDL- and total cholesterol, age at menarche, testosterone levels, sex hormone binding globulin levels (adjusted for BMI), birthweight, adulthood height, lean body mass (for women), four plasma fatty acids, circulating 25-hydroxyvitamin D and education years. Eight associations remained after adjustment for adulthood BMI. We additionally identified 21 suggestive risk factors (p < 0.05), such as alcohol consumption, breakfast skipping, daytime napping, short sleep, urinary sodium, and certain amino acids and inflammatory factors.
Conclusions/interpretation: The present study verified several previously reported risk factors and identified novel potential risk factors for type 2 diabetes. Prevention strategies for type 2 diabetes should be considered from multiple perspectives on obesity, mental health, sleep quality, education level, birthweight and smoking.
Keywords: Mendelian randomisation; Prevention; Review; Risk factors; Type 2 diabetes.
Similar articles
- Influence of puberty timing on adiposity and cardiometabolic traits: A Mendelian randomisation study.PLoS Med. 2018 Aug 28;15(8):e1002641. doi: 10.1371/journal.pmed.1002641. eCollection 2018 Aug.PMID: 30153260 Free PMC article.
- Appraising the role of previously reported risk factors in epithelial ovarian cancer risk: A Mendelian randomization analysis.PLoS Med. 2019 Aug 7;16(8):e1002893. doi: 10.1371/journal.pmed.1002893. eCollection 2019 Aug.PMID: 31390370 Free PMC article.
- Association of genetic variants related to plasma fatty acids with type 2 diabetes mellitus and glycaemic traits: a Mendelian randomisation study.Diabetologia. 2020 Jan;63(1):116-123. doi: 10.1007/s00125-019-05019-0. Epub 2019 Nov 5.PMID: 31690987 Free PMC article.
- Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies.Diabetologia. 2012 Aug;55(8):2173-82. doi: 10.1007/s00125-012-2544-y. Epub 2012 Apr 15.PMID: 22526608 Review.
- Vitamin D concentration, obesity, and risk of diabetes: a mendelian randomisation study.Lancet Diabetes Endocrinol. 2014 Apr;2(4):298-306. doi: 10.1016/S2213-8587(13)70200-6. Epub 2014 Jan 28.PMID: 24703048 Review.
No hay comentarios:
Publicar un comentario